Arena Capital Advisors’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-300,000
Closed -$2.99M 453
2021
Q2
$2.99M Hold
300,000
0.25% 138
2021
Q1
$2.97M Buy
+300,000
New +$3.04M 0.29% 118

Other funds holding EQHA.U

Arena Capital Advisors's EQHA.U Position: Q3 2021 in Review

Arena Capital Advisors sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q3 2021, closing a stake of 300,000 shares — an estimated $2.99M sold.

Arena Capital Advisors first reported a position in EQHA.U in Q1 2021 and held it in 2 quarters. The position peaked at $2.99M in Q2 2021. 35 funds tracked by Wall St. Rank hold EQHA.U as of Q3 2021.

  • Arena Capital Advisors reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q3 2021 after selling out during the quarter.
  • Arena Capital Advisors sold 300,000 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q3 2021, an estimated $2.99M.
  • Arena Capital Advisors first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 2 quarters.
  • Arena Capital Advisors's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $2.99M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q3 2021.

Based on Arena Capital Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.